KEGG   DRUG: Lidocaine
Entry
D00358                      Drug                                   
Name
Lidocaine (JP18/USP/INN);
Dentipatch (TN);
Xylocaine (TN)
Product
LIDODERM (Endo Pharmaceuticals), LIDODERM (TPU Pharma), ZTLIDO (Scilex Pharmaceuticals)
  Generic
LIDOCAINE (A-S Medication Solutions), LIDOCAINE (AVKARE), LIDOCAINE (Actavis Pharma), LIDOCAINE (Actavis Pharma), LIDOCAINE (Advanced Rx Pharmacy of Tennessee), LIDOCAINE (Advanced Rx Pharmacy of Tennessee), LIDOCAINE (Advanced Rx Pharmacy of Tennessee), LIDOCAINE (Advanced Rx Pharmacy of Tennessee), LIDOCAINE (Advanced Rx Pharmacy of Tennessee), LIDOCAINE (Advanced Rx of Tennessee), LIDOCAINE (Advanced Rx of Tennessee), LIDOCAINE (Alembic Pharmaceuticals), LIDOCAINE (Amneal Pharmaceuticals LLC), LIDOCAINE (Amneal Pharmaceuticals LLC), LIDOCAINE (Amneal Pharmaceuticals LLC), LIDOCAINE (Asclemed USA), LIDOCAINE (Asclemed USA), LIDOCAINE (Asclemed USA), LIDOCAINE (Asclemed USA), LIDOCAINE (Asclemed USA), LIDOCAINE (Aurobindo Pharma Limited), LIDOCAINE (AvKARE), LIDOCAINE (AvKARE), LIDOCAINE (Bryant Ranch Prepack), LIDOCAINE (Bryant Ranch Prepack), LIDOCAINE (Bryant Ranch Prepack), LIDOCAINE (Bryant Ranch Prepack), LIDOCAINE (Bryant Ranch Prepack), LIDOCAINE (Bryant Ranch Prepack), LIDOCAINE (Bryant Ranch Prepack), LIDOCAINE (Bryant Ranch Prepack), LIDOCAINE (Bryant Ranch Prepack), LIDOCAINE (Bryant Ranch Prepack), LIDOCAINE (Bryant Ranch Prepack), LIDOCAINE (Cardinal Health 107), LIDOCAINE (Cardinal Health 107), LIDOCAINE (DIRECT RX), LIDOCAINE (DIRECT RX), LIDOCAINE (DIRECTRX), LIDOCAINE (Direct_Rx), LIDOCAINE (Direct_Rx), LIDOCAINE (Direct_Rx), LIDOCAINE (Endo USA), LIDOCAINE (Fougera Pharmaceuticals), LIDOCAINE (Glenmark Pharmaceuticals), LIDOCAINE (Golden State Medical Supply), LIDOCAINE (Golden State Medical Supply), LIDOCAINE (IPG Pharmaceuticals), LIDOCAINE (Lake Erie Medical DBA Quality Care Products LLC), LIDOCAINE (Macleods Pharmaceuticals Limited), LIDOCAINE (Mylan Pharmaceuticals), LIDOCAINE (Northstar Rx LLC), LIDOCAINE (NuCare Pharmaceuticals), LIDOCAINE (Preferred Pharmaceuticals), LIDOCAINE (Preferred Pharmaceuticals), LIDOCAINE (Preferred Pharmaceuticals), LIDOCAINE (Preferred Pharmaceuticals), LIDOCAINE (Preferred Pharmaceuticals), LIDOCAINE (Preferred Pharmaceuticals), LIDOCAINE (Proficient Rx LP), LIDOCAINE (Proficient Rx LP), LIDOCAINE (Proficient Rx LP), LIDOCAINE (Proficient Rx LP), LIDOCAINE (Proficient Rx LP), LIDOCAINE (Proficient Rx LP), LIDOCAINE (Proficient Rx LP), LIDOCAINE (Proficient Rx LP), LIDOCAINE (Proficient Rx LP), LIDOCAINE (Proficient Rx LP), LIDOCAINE (Proficient Rx LP), LIDOCAINE (PureTek Corporation), LIDOCAINE (QUAGEN PHARMACEUTICALS LLC), LIDOCAINE (Quality Care Products LLC), LIDOCAINE (Quality Care Products), LIDOCAINE (Quality Care Products), LIDOCAINE (Quality Care Products), LIDOCAINE (Quality Care Products), LIDOCAINE (Quality Care Products), LIDOCAINE (Quality Care; Products), LIDOCAINE (REMEDYREPACK), LIDOCAINE (REMEDYREPACK), LIDOCAINE (REMEDYREPACK), LIDOCAINE (REMEDYREPACK), LIDOCAINE (REMEDYREPACK), LIDOCAINE (Septodont), LIDOCAINE (St. Mary's Medical Park Pharmacy), LIDOCAINE (St. Mary's Medical Park Pharmacy), LIDOCAINE (Strides Pharma Science Limited), LIDOCAINE (Taro Pharmaceuticals U.S.A.), LIDOCAINE (Taro Pharmaceuticals U.S.A.), LIDOCAINE (medsource pharmaceuticals), LIDOCAINE (medsource pharmaceuticals), LIDOCAINE (medsource pharmaceuticals), LIDOCAINE (medsource pharmaceuticals), LIDOCAINE (medsource pharmaceuticals), LIDOCAINE (medsource pharmaceuticals), LIDOCAINE 5% (NuCare Pharmaceuticals), LIDOCAINE 5% (REMEDYREPACK), LIDOCAINE 5% (ST. MARY'S MEDICAL PARK PHARMACY), LIDOCAINE 5% (YARAL Pharma), LIDOCAINE 5% PATCH (Medcore LLC), LIDOCAINE PATCH (Direct_Rx), LIDOCAN IV (PURETEK CORPORATION), TRIDACAINE II (Trifluent Pharma LLC), TRIDACAINE III (Trifluent Pharma LLC), TRIDACAINE XL (Trifluent Pharma LLC)
Formula
C14H22N2O
Exact mass
234.1732
Mol weight
234.34
Structure
Simcomp
Class
Cardiovascular agent
 DG01653  Antiarrhythmics
  DG01652  Class I antiarrhythmic agent
   DG01651  Class Ib antiarrhythmic agent
Neuropsychiatric agent
 DG02030  Anesthetics
  DG01675  Local anesthetic
   DG01673  Amide type local anesthetic
Metabolizing enzyme substrate
 DG01892  CYP1A2 substrate
 DG01633  CYP3A/CYP3A4 substrate
  DG02913  CYP3A4 substrate
Remark
Same as: C07073
Therapeutic category: 1214
ATC code: C01BB01 C05AD01 D04AB01 N01BB02 R02AD02 S01HA07 S02DA01
Chemical structure group: DG00196
Product (DG00196): D00358<JP/US> D02086<JP/US> D08127<JP/US>
Product (mixture): D02740<JP/US> D04688<JP> D04692<JP> D04881<JP> D07742<JP> D11553<US>
Efficacy
Anesthetic (topical), Antiarrhythmic, Sodium channel blocker
Comment
Anilide derivative
Target
SCN1A [HSA:6323] [KO:K04833]
SCN2A [HSA:6326] [KO:K04834]
SCN3A [HSA:6328] [KO:K04836]
SCN4A [HSA:6329] [KO:K04837]
SCN5A [HSA:6331] [KO:K04838]
SCN8A [HSA:6334] [KO:K04840]
SCN9A [HSA:6335] [KO:K04841]
SCN10A [HSA:6336] [KO:K04842]
SCN11A [HSA:11280] [KO:K04843]
  Pathway
hsa04261  Adrenergic signaling in cardiomyocytes
hsa04728  Dopaminergic synapse
Metabolism
Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]
Interaction
Structure map
map07037  Antiarrhythmic drugs
map07231  Sodium channel blocking drugs
Other map
map00982  Drug metabolism - cytochrome P450
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 C CARDIOVASCULAR SYSTEM
  C01 CARDIAC THERAPY
   C01B ANTIARRHYTHMICS, CLASS I AND III
    C01BB Antiarrhythmics, class Ib
     C01BB01 Lidocaine
      D00358  Lidocaine (JP18/USP/INN) <JP/US>
  C05 VASOPROTECTIVES
   C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
    C05AD Local anesthetics
     C05AD01 Lidocaine
      D00358  Lidocaine (JP18/USP/INN) <JP/US>
 D DERMATOLOGICALS
  D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
   D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
    D04AB Anesthetics for topical use
     D04AB01 Lidocaine
      D00358  Lidocaine (JP18/USP/INN) <JP/US>
 N NERVOUS SYSTEM
  N01 ANESTHETICS
   N01B ANESTHETICS, LOCAL
    N01BB Amides
     N01BB02 Lidocaine
      D00358  Lidocaine (JP18/USP/INN) <JP/US>
 R RESPIRATORY SYSTEM
  R02 THROAT PREPARATIONS
   R02A THROAT PREPARATIONS
    R02AD Anesthetics, local
     R02AD02 Lidocaine
      D00358  Lidocaine (JP18/USP/INN) <JP/US>
 S SENSORY ORGANS
  S01 OPHTHALMOLOGICALS
   S01H LOCAL ANESTHETICS
    S01HA Local anesthetics
     S01HA07 Lidocaine
      D00358  Lidocaine (JP18/USP/INN) <JP/US>
  S02 OTOLOGICALS
   S02D OTHER OTOLOGICALS
    S02DA Analgesics and anesthetics
     S02DA01 Lidocaine
      D00358  Lidocaine (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
 Anesthetics
  Local Anesthetics
   Lidocaine
    D00358  Lidocaine (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  12  Agents affecting peripheral nervous system
   121  Local anesthetics
    1214  Xylidines
     D00358  Lidocaine (JP18/USP/INN)
Classification of Japanese OTC drugs [BR:br08313]
 Agents for  urogenital organs and anus
  30 Hemorrhoid drugs for external use
   D00358  Lidocaine (JP18/USP/INN)
 Agents for integumentary system
  57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
   D00358  Lidocaine (JP18/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
 Second-class OTC drugs
  Inorganic and organic chemicals
   Lidocaine
    D00358  Lidocaine (JP18/USP/INN)
Drug groups [BR:br08330]
 Cardiovascular agent
  DG01653  Antiarrhythmics
   DG01652  Class I antiarrhythmic agent
    DG01651  Class Ib antiarrhythmic agent
     DG00196  Lidocaine
      D00358  Lidocaine
 Neuropsychiatric agent
  DG02030  Anesthetics
   DG01675  Local anesthetic
    DG01673  Amide type local anesthetic
     DG00196  Lidocaine
      D00358  Lidocaine
 Metabolizing enzyme substrate
  DG01892  CYP1A2 substrate
   DG00196  Lidocaine
    D00358  Lidocaine
  DG01633  CYP3A/CYP3A4 substrate
   DG02913  CYP3A4 substrate
    DG00196  Lidocaine
     D00358  Lidocaine
Drug classes [BR:br08332]
 Cardiovascular agent
  DG01653  Antiarrhythmics
   D00358  Lidocaine
Target-based classification of drugs [BR:br08310]
 Ion channels
  Voltage-gated ion channels
   Sodium channels
    SCN1A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN2A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN3A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN4A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN5A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN8A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN9A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN10A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN11A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00358  Lidocaine
  D00358  Lidocaine injection
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D00358
Drug groups [BR:br08330]
 Cardiovascular agent
  DG01653  Antiarrhythmics
   DG01652  Class I antiarrhythmic agent
    DG01651  Class Ib antiarrhythmic agent
     DG00196  Lidocaine
 Neuropsychiatric agent
  DG02030  Anesthetics
   DG01675  Local anesthetic
    DG01673  Amide type local anesthetic
     DG00196  Lidocaine
 Metabolizing enzyme substrate
  DG01892  CYP1A2 substrate
   DG00196  Lidocaine
  DG01633  CYP3A/CYP3A4 substrate
   DG02913  CYP3A4 substrate
    DG00196  Lidocaine
Other DBs
CAS: 137-58-6
PubChem: 7847424
ChEBI: 6456
PDB-CCD: LQZ[PDBj]
LigandBox: D00358
NIKKAJI: J5.631F
KCF data

ATOM        17
            1   C8y C    23.2602  -19.0646
            2   N1b N    24.4935  -19.7778
            3   C8y C    22.0325  -19.7836
            4   C8y C    23.2602  -17.6441
            5   C5a C    25.7213  -19.0587
            6   C8x C    20.8049  -19.0646
            7   C1a C    22.0384  -21.1983
            8   C8x C    22.0325  -16.9367
            9   C1a C    24.4818  -16.9367
            10  C1b C    26.9488  -19.7778
            11  O5a O    25.7096  -17.6332
            12  C8x C    20.8049  -17.6441
            13  N1c N    28.1823  -19.0587
            14  C1b C    29.4158  -19.7778
            15  C1b C    28.1823  -17.6441
            16  C1a C    30.6317  -19.0587
            17  C1a C    29.4158  -16.9309
BOND        17
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 1
            5     3   6 1
            6     3   7 1
            7     4   8 2
            8     4   9 1
            9     5  10 1
            10    5  11 2
            11    6  12 2
            12   10  13 1
            13   13  14 1
            14   13  15 1
            15   14  16 1
            16   15  17 1
            17    8  12 1

» Japanese version   » Back

  All links  
Ontology (10)   
   KEGG BRITE (10)   
Pathway (3)   
   KEGG PATHWAY (3)   
Drug (3)   
   KEGG DGROUP (1)   
   LigandBox (1)   
   SIDER (1)   
Chemical substance (8)   
   KEGG COMPOUND (1)   
   PubChem (1)   
   ChEBI (1)   
   HMDB (1)   
   HSDB (1)   
   MASSBANK (1)   
   NIKKAJI (1)   
   PDB-CCD (1)   
Gene (18)   
   KEGG ORTHOLOGY (9)   
   KEGG GENES (9)   
All databases (42)   

Download RDF
KEGG   COMPOUND: C07073
Entry
C07073                      Compound                               
Name
Lidocaine
Formula
C14H22N2O
Exact mass
234.1732
Mol weight
234.34
Structure
Remark
Same as: D00358
Reaction
R08293 R08294 R08300
Pathway
map00982  Drug metabolism - cytochrome P450
Enzyme
1.14.14.1       1.14.14.-       3.1.1.1
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 C CARDIOVASCULAR SYSTEM
  C01 CARDIAC THERAPY
   C01B ANTIARRHYTHMICS, CLASS I AND III
    C01BB Antiarrhythmics, class Ib
     C01BB01 Lidocaine
      D00358  Lidocaine (JP18/USP/INN) <JP/US>
  C05 VASOPROTECTIVES
   C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
    C05AD Local anesthetics
     C05AD01 Lidocaine
      D00358  Lidocaine (JP18/USP/INN) <JP/US>
 D DERMATOLOGICALS
  D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
   D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
    D04AB Anesthetics for topical use
     D04AB01 Lidocaine
      D00358  Lidocaine (JP18/USP/INN) <JP/US>
 N NERVOUS SYSTEM
  N01 ANESTHETICS
   N01B ANESTHETICS, LOCAL
    N01BB Amides
     N01BB02 Lidocaine
      D00358  Lidocaine (JP18/USP/INN) <JP/US>
 R RESPIRATORY SYSTEM
  R02 THROAT PREPARATIONS
   R02A THROAT PREPARATIONS
    R02AD Anesthetics, local
     R02AD02 Lidocaine
      D00358  Lidocaine (JP18/USP/INN) <JP/US>
 S SENSORY ORGANS
  S01 OPHTHALMOLOGICALS
   S01H LOCAL ANESTHETICS
    S01HA Local anesthetics
     S01HA07 Lidocaine
      D00358  Lidocaine (JP18/USP/INN) <JP/US>
  S02 OTOLOGICALS
   S02D OTHER OTOLOGICALS
    S02DA Analgesics and anesthetics
     S02DA01 Lidocaine
      D00358  Lidocaine (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
 Anesthetics
  Local Anesthetics
   Lidocaine
    D00358  Lidocaine (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  12  Agents affecting peripheral nervous system
   121  Local anesthetics
    1214  Xylidines
     D00358  Lidocaine (JP18/USP/INN)
Classification of Japanese OTC drugs [BR:br08313]
 Agents for  urogenital organs and anus
  30 Hemorrhoid drugs for external use
   D00358  Lidocaine (JP18/USP/INN)
 Agents for integumentary system
  57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
   D00358  Lidocaine (JP18/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
 Second-class OTC drugs
  Inorganic and organic chemicals
   Lidocaine
    D00358  Lidocaine (JP18/USP/INN)
Drug groups [BR:br08330]
 Cardiovascular agent
  DG01653  Antiarrhythmics
   DG01652  Class I antiarrhythmic agent
    DG01651  Class Ib antiarrhythmic agent
     DG00196  Lidocaine
      D00358  Lidocaine
 Neuropsychiatric agent
  DG02030  Anesthetics
   DG01675  Local anesthetic
    DG01673  Amide type local anesthetic
     DG00196  Lidocaine
      D00358  Lidocaine
 Metabolizing enzyme substrate
  DG01892  CYP1A2 substrate
   DG00196  Lidocaine
    D00358  Lidocaine
  DG01633  CYP3A/CYP3A4 substrate
   DG02913  CYP3A4 substrate
    DG00196  Lidocaine
     D00358  Lidocaine
Drug classes [BR:br08332]
 Cardiovascular agent
  DG01653  Antiarrhythmics
   D00358  Lidocaine
Target-based classification of drugs [BR:br08310]
 Ion channels
  Voltage-gated ion channels
   Sodium channels
    SCN1A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN2A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN3A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN4A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN5A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN8A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN9A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN10A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
    SCN11A
     D00358  Lidocaine (JP18/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00358  Lidocaine
  D00358  Lidocaine injection
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D00358
Other DBs
CAS: 137-58-6
PubChem: 9284
ChEBI: 6456
PDB-CCD: LQZ[PDBj]
NIKKAJI: J5.631F
KCF data

ATOM        17
            1   C8y C    23.2602  -19.0646
            2   N1b N    24.4935  -19.7778
            3   C8y C    22.0325  -19.7836
            4   C8y C    23.2602  -17.6441
            5   C5a C    25.7213  -19.0587
            6   C8x C    20.8049  -19.0646
            7   C1a C    22.0384  -21.1983
            8   C8x C    22.0325  -16.9367
            9   C1a C    24.4818  -16.9367
            10  C1b C    26.9488  -19.7778
            11  O5a O    25.7096  -17.6332
            12  C8x C    20.8049  -17.6441
            13  N1c N    28.1823  -19.0587
            14  C1b C    29.4158  -19.7778
            15  C1b C    28.1823  -17.6441
            16  C1a C    30.6317  -19.0587
            17  C1a C    29.4158  -16.9309
BOND        17
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 1
            5     3   6 1
            6     3   7 1
            7     4   8 2
            8     4   9 1
            9     5  10 1
            10    5  11 2
            11    6  12 2
            12   10  13 1
            13   13  14 1
            14   13  15 1
            15   14  16 1
            16   15  17 1
            17    8  12 1

» Japanese version

  All links  
Pathway (1)   
   KEGG PATHWAY (1)   
Drug (1)   
   KEGG DRUG (1)   
Chemical substance (14)   
   PubChem (1)   
   ChEBI (1)   
   HMDB (1)   
   HSDB (1)   
   MASSBANK (9)   
   NIKKAJI (1)   
Chemical reaction (5)   
   KEGG ENZYME (2)   
   KEGG REACTION (3)   
Gene (199)   
   KEGG GENES (199)   
All databases (220)   

Download RDF
DBGET integrated database retrieval system